The functional channel in human T lymphocytes is composed of four identical KCNB1 sub-units, and several peptide inhibitor of KCNB1 have been developed as therapy for autoimmune diseases [8] such as type 1 diabetes mellitus and rheumatoid arthritis. Here, KCNB1 is linked to autoimmune disease.